Entera Bio Ltd. (ENTX) vs Pyxis Oncology, Inc. (PYXS)
A side-by-side comparison of Entera Bio Ltd. and Pyxis Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENTX
Entera Bio Ltd.
$2.58HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
PYXS
Pyxis Oncology, Inc.
$2.10HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
Total return — ENTX vs PYXS
growth of $100 · dividends reinvested · last 5yENTX -41.9% (-10.3%/yr)PYXS -83.0% (-29.9%/yr)ENTX compounded faster over this window
ENTX PYXS
ENTX vs PYXS: by the numbers
- •PYXS is the larger company ($133M vs $127M market cap).
- •Both run net losses; PYXS's is the smaller (-803.83% vs -27235.71% net margin).
Metrics side by side
Valuation
| Metric | ENTX | PYXS |
|---|---|---|
| P/S ratio | N/A | 12.07 |
| P/B ratio | 17.47 | 11.65 |
Profitability
| Metric | ENTX | PYXS |
|---|---|---|
| Gross margin | 0.00% | 82.77% |
| Operating margin | -27450.00% | -609.18% |
| Net margin | -27235.71% | -803.83% |
| ROE | -234.42% | -775.59% |
| ROIC | -82.87% | -314.66% |
Growth (annualized)
| Metric | ENTX | PYXS |
|---|---|---|
| Total return CAGR (5Y) | -10.57% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.